Better Therapeutics, Inc. BTTX
0.00 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.0001 Day range 0.0001
0.0001 52-week range 0.0002
- YTD
- 0.00%
- 1 year
- 0.00%
Analyst view
Consensus: buy
Buy
Price target (mean) 5.25 +5249900.0% upside
Now 0.0001
- Target (low)
- 1.50
- Target (mean)
- 5.25
- Target (high)
- 9.00
Ratings (-1m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 2
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.12 | -0.12 – -0.12 | -0.37 | +67.6% | 0 | 0.0% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.39 | 0.0% | 0 | 0.0% | 0 |
| Current year | -0.81 | -0.81 – -0.81 | -1.69 | +52.1% | 0 | 0.0% | 1 |
| Next year | -1.00 | -1.00 – -1.00 | -0.81 | -23.5% | 3.80M | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 9, 2023 | Chardan Capital | Reiterated | Buy | Buy |
| Aug 9, 2023 | Lake Street | Maintained | Buy | Buy |
| Apr 13, 2023 | Lake Street | Maintained | — | Buy |
| Mar 30, 2023 | Chardan Capital | Maintained | — | Buy |
| Nov 14, 2022 | Chardan Capital | Maintained | — | Buy |
| Jul 28, 2022 | Chardan Capital | Maintained | — | Buy |
| Mar 15, 2022 | Chardan Capital | Maintained | — | Buy |
| Nov 23, 2021 | Chardan Capital | Initiated | — | Buy |
| Nov 9, 2021 | Cowen & Co. | Initiated | — | Outperform |